The management report, 'The Pharmacoeconomics Outlook: Turning
value-for-money requirements into a competitive advantage' assesses the impact
that the emerging discipline of pharmacoeconomics has had on the pharmaceutical
industry and shows how companies can utilize pharmacoeconomic modeling to gain a
competitive edge.
This report examines the most commonly used pharmacoeconomic methodologies
with respect to both study perspective and the range of R&D costs that can
be analyzed. In addition to this, the strategic applications of
pharmacoeconomics at three critical points in the value chain: R&D,
pricing/reimbursement and marketing are also detailed in this report.
Pharmacoeconomics can improve the productivity of R&D processes by focusing
resources on the most commercially attractive products through early
consideration of pricing and reimbursement issues. This new management report
will guide you on the most suitable pharmacoeconomic methodologies to use for
drugs in development, which will help you to assess viability and increase
profitability of your products, pre- and post-launch.
View Cart
